$207.94
-0.03[-0.01%]
At close: Apr 24
$207.94
0[0.00%]
After Hours: 4:00PM EDT
Laboratory Corp
(NYSE:LH)Laboratory Corp Stock (NYSE:LH), Analyst Ratings, Price Targets, Predictions
Laboratory Corp of America Holdings has a consensus price target of $265.21, established from looking at the 57 latest analyst ratings. The last 3 analyst ratings were released from Argus Research, Leerink Partners, and Evercore ISI Group on March 25, 2024, February 26, 2024, and February 9, 2024. With an average price target of $166.67 between Argus Research, Leerink Partners, and Evercore ISI Group, there's an implied -19.85% downside for Laboratory Corp of America Holdings from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Argus Research
Leerink Partners
Evercore ISI Group
Barclays
JP Morgan
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Laboratory Corp
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/25/2024 | LH | Buy Now | Laboratory Corp | $207.94 | — | Argus Research | David Toung | — | Upgrade | Hold → Buy | Get Alert |
| 02/26/2024 | LH | Buy Now | Laboratory Corp | $207.94 | 25.04% | Leerink Partners | Michael Cherny | → $260 | Initiates | → Outperform | Get Alert |
| 02/09/2024 | LH | Buy Now | Laboratory Corp | $207.94 | 15.42% | Evercore ISI Group | Elizabeth Anderson | → $240 | Initiates | → In-Line | Get Alert |
| 01/03/2024 | LH | Buy Now | Laboratory Corp | $207.94 | 6.76% | Barclays | Stephanie Davis | → $222 | Initiates | → Equal-Weight | Get Alert |
| 11/17/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 25.52% | JP Morgan | John Stansel | $259 → $261 | Maintains | Overweight | Get Alert |
| 10/31/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 10.61% | Mizuho | Ann Hynes | $257 → $230 | Maintains | Buy | Get Alert |
| 09/21/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 10.61% | B of A Securities | Derik De Bruin | $238 → $230 | Maintains | Buy | Get Alert |
| 09/18/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 13.98% | Baird | Eric Coldwell | $251 → $237 | Maintains | Outperform | Get Alert |
| 09/15/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 29.85% | Truist Securities | Ryan MacDonald | → $270 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 23.59% | Mizuho | Ann Hynes | → $257 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 0.99% | HSBC | Morten Herholdt | → $210 | Initiates | → Hold | Get Alert |
| 08/14/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 29.85% | Wells Fargo | Timothy Daley | $290 → $270 | Maintains | Overweight | Get Alert |
| 08/03/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 25.04% | Morgan Stanley | Ricky Goldwasser | $285 → $260 | Maintains | Overweight | Get Alert |
| 08/02/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 11.09% | Credit Suisse | Jonathan Yong | $247.41 → $231 | Maintains | Outperform | Get Alert |
| 07/31/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 20.71% | Baird | Eric Coldwell | $255 → $251 | Maintains | Outperform | Get Alert |
| 07/28/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 29.85% | Truist Securities | Ryan MacDonald | $275 → $270 | Maintains | Buy | Get Alert |
| 06/05/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 38.5% | Credit Suisse | Jonathan Yong | → $288 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 23.59% | Mizuho | Ann Hynes | $277 → $257 | Maintains | Buy | Get Alert |
| 05/10/2023 | LH | Buy Now | Laboratory Corp | $207.94 | 37.06% | Morgan Stanley | Ricky Goldwasser | $295 → $285 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Laboratory Corp (LH)?
The latest price target for Laboratory Corp (NYSE: LH) was reported by Argus Research on March 25, 2024. The analyst firm set a price target for $0.00 expecting LH to fall to within 12 months (a possible -100.00% downside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Laboratory Corp (LH)?
The latest analyst rating for Laboratory Corp (NYSE: LH) was provided by Argus Research, and Laboratory Corp upgraded their buy rating.
When was the last upgrade for Laboratory Corp (LH)?
The last upgrade for Laboratory Corp of America Holdings happened on March 25, 2024 when Argus Research raised their price target to N/A. Argus Research previously had a hold for Laboratory Corp of America Holdings.
When was the last downgrade for Laboratory Corp (LH)?
The last downgrade for Laboratory Corp of America Holdings happened on December 12, 2022 when Citigroup changed their price target from N/A to $250 for Laboratory Corp of America Holdings.
When is the next analyst rating going to be posted or updated for Laboratory Corp (LH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Laboratory Corp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Laboratory Corp was filed on March 25, 2024 so you should expect the next rating to be made available sometime around March 25, 2025.
Is the Analyst Rating Laboratory Corp (LH) correct?
While ratings are subjective and will change, the latest Laboratory Corp (LH) rating was a upgraded with a price target of $0.00 to $0.00. The current price Laboratory Corp (LH) is trading at is $207.94, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.